Hypermagnesemia and hyperphosphatemia are highly prevalent in COVID-19 patients and increase the risk of death. Malinowska J, Malecka-Gieldowska M, Bankowska D, Borecka K, et al. Int J Infect Dis 2022 Jul 5. pii: S1201-9712(22)00394.

Read + Share

Amedeo Smart

Independent Medical Education

Malinowska J, Malecka-Gieldowska M, Bankowska D, Borecka K, et al. Hypermagnesemia and hyperphosphatemia are highly prevalent in COVID-19 patients and increase the risk of death. Int J Infect Dis 2022 Jul 5. pii: S1201-9712(22)00394.
PMID: 35803468